Journal of Controlled Release
Dual-transporter-targeted oral semaglutide nanomicelles enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes
Experiments in animalsInterventions
Papers by Laxman Subedi
1 result
1 result